STRAP is overexpressed in other cancers and has been associated with a more aggressive phenotype [6,8]; this provides an exciting avenue for future work to investigate STRAP expression levels in patient neuroblastoma specimens as a potential predictor for high-risk disease. This evidence concerns the gene STRAP and neuroblastoma.